When patients develop acne keloids—thick, raised scars that extend beyond the original acne lesion—many walk away from their dermatologist’s office without fully understanding that their scar type requires specialized, targeted treatment different from standard acne care. While the specific percentage of patients receiving inadequate counseling about scar-specific treatment varies, recent research confirms a documented gap in patient education around keloid management. This gap matters because keloids don’t respond to over-the-counter acne treatments, professional acne facials, or even prescription acne medications. They require dedicated protocols developed specifically for their unique characteristics—protocols that work only when patients understand they exist and actively pursue them. The disconnect between what patients know and what they need to know begins at diagnosis.
A patient might visit their dermatologist for acne treatment, develop a keloid as a complication or predisposition, receive minimal counseling about why this scar looks and behaves differently, and then spend months or years trying ineffective approaches. Consider a 28-year-old woman with inflammatory acne who develops a raised, spreading scar on her jawline after a severe breakout. If her dermatologist doesn’t explicitly explain that this keloid requires injection therapy, laser treatment, or other specialized interventions—rather than benzoyl peroxide or retinoids—she may delay seeking effective care by years, watching the scar grow larger and become psychologically more distressing. The burden of this gap falls not just on patient outcomes but on mental health. Scars and keloids impose significant psychological burdens, yet patients often lack access to clear, reliable information about what treatments exist, which ones actually work, and what realistic expectations should be.
Table of Contents
- Why Acne Keloids Demand Different Treatment Than Regular Acne Scars
- The Documented Patient Education Gap in Keloid Management
- Psychological and Quality-of-Life Impact of Untreated Keloids
- Types of Specialized Keloid Treatments Patients Should Know About
- The Risk of Worsening Keloids With Inappropriate Treatments
- The ASAP Protocol and Evidence-Based Outcomes
- Toward Better Patient Communication in Dermatology
- Conclusion
Why Acne Keloids Demand Different Treatment Than Regular Acne Scars
Acne keloids are a distinct category of scarring that many patients—and sometimes physicians—conflate with other post-acne scar types. Unlike atrophic scars (depressed, pitted scars) or hypertrophic scars (raised but confined within the original wound boundary), keloids are defined by their aggressive growth pattern: they extend beyond the original acne lesion and continue proliferating long after the initial wound has healed. This biological behavior requires a fundamentally different treatment strategy than atrophic scarring. An atrophic scar might respond well to microneedling or subcision, but these approaches can actually worsen keloids by triggering further collagen deposition.
The distinction matters because most standard acne scar treatments in dermatology offices are designed for atrophic scars—the most common type of acne scarring. When a patient with a keloid receives treatment intended for depressed scars, results range from ineffective to harmful. This is where the education gap becomes clinically significant. Patients need to know early whether they have a keloid, hypertrophic scar, or atrophic scar, because the answer determines which dermatologists to see, which treatments to pursue, and which ones to avoid entirely.
The Documented Patient Education Gap in Keloid Management
Recent medical literature confirms that patient education around specialized scar treatment is inconsistent. A 2024-2025 study published in JMIR Medical Informatics found that “poor patient compliance with glucocorticoids injection was found in clinical practice, so few patients after discharge completed regular hormone injection treatment, indicating the need to enhance patient education.” This finding points to a twofold problem: first, that keloid patients often don’t receive clear guidance about why repeated treatment is necessary, and second, that without understanding the rationale, they abandon effective therapies prematurely. The practical consequence is that many patients begin keloid treatment—such as intralesional corticosteroid injections, a first-line intervention—but discontinue after one or two sessions because they don’t understand that keloids require repeated, ongoing therapy.
A single injection may flatten the keloid temporarily, but without follow-up treatments spaced four to six weeks apart, the keloid often returns to its original size. When patients aren’t told this upfront, they perceive the treatment as a failure and stop returning. The specialist’s office notes may document this as “patient non-compliance,” but the root cause is inadequate patient education about what to expect and why persistence is necessary.
Psychological and Quality-of-Life Impact of Untreated Keloids
The decision to delay or forgo specialized keloid treatment carries psychological consequences that extend far beyond appearance. Keloids, by their very nature, grow larger and more visible over months and years. A small raised scar can become a pronounced, often darkly pigmented, thick growth that draws attention and can trigger shame, social withdrawal, and depressive symptoms. Patients report avoiding social situations, wearing concealing clothing, or canceling plans based on scar visibility. The psychological burden of untreated keloids is documented in medical literature, yet this emotional toll is rarely discussed in routine dermatology consultations where patients receive acne care.
When a patient develops a keloid after acne and isn’t told that specialized treatment exists—or isn’t educated about the importance of early intervention—they often spend months in a state of normalizing the scar, hoping it will fade on its own. It won’t. Keloids don’t regress spontaneously; they grow. The patient’s delay in seeking specialized treatment means the keloid has had additional time to enlarge, making treatment more difficult and requiring more intensive interventions. Earlier specialized treatment—initiated within weeks or months of the keloid appearing—typically requires fewer injections sessions and produces better outcomes than treatment delayed by years.
Types of Specialized Keloid Treatments Patients Should Know About
Effective keloid treatment is built on specialized protocols that differ fundamentally from acne care. Intralesional corticosteroid injections remain a first-line treatment, but they must be performed by practitioners trained in the specific concentrations, injection depths, and spacing required for keloids. Triamcinolone acetonide, typically at concentrations of 10 to 40 mg/mL, is injected directly into the keloid tissue, requiring technical skill and experience.
Patients should understand that this treatment hurts during injection and requires multiple sessions over months. Other specialized treatments include laser therapy (particularly pulsed dye lasers, which target vascularity and can reduce redness and thickness), silicone-based therapies (sheets or ointments that can be worn for extended periods), pressure garments, and cryotherapy (freezing the keloid). The limitation patients should know is that no single treatment works for everyone, and many practitioners recommend combination approaches—for example, serial steroid injections combined with silicone therapy. A patient who isn’t educated about these options may pursue only one approach, exhaust its effectiveness, and give up rather than combining modalities.
The Risk of Worsening Keloids With Inappropriate Treatments
One of the most critical gaps in patient education is the warning about treatments that can worsen keloids. Patients with untreated keloids are vulnerable to pursuing interventions that sound reasonable but are actually contraindicated. Surgical excision of a keloid without simultaneous or follow-up specialized treatment often results in a larger, more aggressive keloid at the excision site—a phenomenon well documented in dermatologic literature. A patient who undergoes surgery to “remove” a keloid without understanding that the surgical wound itself can trigger keloid regrowth may end up worse than before.
Similarly, aggressive microneedling, professional peels, and other resurfacing treatments can stimulate keloid growth rather than improve them. Patients searching online for “how to treat acne scars” may find these options and pursue them without understanding their specific scar type. The warning needs to be explicit and early: if your scar is a keloid—if it’s raised, thick, and continues growing beyond the original acne lesion—then avoid any procedure that injures or resurfaces the skin without concurrent specialized keloid treatment. The downside of aggressive home care or unguided professional treatments is genuine harm.
The ASAP Protocol and Evidence-Based Outcomes
One of the most encouraging developments in keloid treatment is the ASAP protocol, evaluated in 2025 research showing robust outcomes. ASAP achieved 82.3% complete lesion flattening with a recurrence rate of only 1.3%—results substantially better than historical keloid treatment outcomes. The ASAP approach represents a structured, evidence-based protocol, though details suggest it combines multiple modalities in a coordinated sequence.
Patients should know that modern keloid treatment, when approached systematically by trained specialists, produces meaningful improvement in the majority of cases. However, the existence of an effective protocol means nothing if patients don’t know about it or if they can’t access practitioners trained in it. The research is encouraging, but it’s only valuable to patients who receive clear direction toward specialized care. Many patients still believe keloids are untreatable or cosmetic-only concerns, not medical problems deserving intervention.
Toward Better Patient Communication in Dermatology
The pathway forward requires dermatologists and acne specialists to integrate patient education about specialized scar treatment into their routine consultations. Rather than viewing keloid treatment as something to address “if the patient asks,” it should be a standard discussion point when acne clears or complications develop. Patients should leave appointments with written information about scar types, warning signs that a scar is becoming a keloid, and the specific steps they’ll need to take if specialized treatment is needed.
Additionally, patient communities and online resources need to distinguish clearly between standard acne scar treatments and keloid-specific interventions. Much of the confusion stems from general “acne scar treatment” information that doesn’t acknowledge that keloids are categorically different. When patients are empowered with specific knowledge—that their scar type requires specific care—they’re more likely to seek it, follow through with it, and achieve better outcomes.
Conclusion
The gap between what acne and keloid patients know and what they need to know remains a real clinical problem. While the exact percentage of patients receiving inadequate counseling about specialized keloid treatment requires further formal study, the documented issues with patient compliance, education, and knowledge confirm the gap exists. Patients deserve clear, early communication about whether their scarring is a keloid, why that distinction matters, and what treatment options exist. The psychological burden of untreated keloids—growing, visible, distressing—is preventable through education and access to specialized care.
If you’ve developed acne keloids and haven’t received explicit counseling about specialized treatment options, the next step is clear: seek a dermatologist with specific experience in keloid management. Ask about steroid injections, laser therapy, combination protocols, and modern approaches like the ASAP protocol. Don’t assume your scar is permanent or that nothing can be done. The research shows that when patients receive proper education and access specialized care, outcomes improve substantially.
